{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:59:44Z","timestamp":1792760384209,"version":"4.5.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["165265"],"award-info":[{"award-number":["165265"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["962950"],"award-info":[{"award-number":["962950"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06144-x","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:54:31Z","timestamp":1772700871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The emerging role of TLR7-mediated signaling in respiratory viral infections and autoimmune diseases"],"prefix":"10.1007","volume":"83","author":[{"given":"Chenxiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson F.","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Karina Nisperuza","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Islamuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9875-983X","authenticated-orcid":false,"given":"Xuebin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"6144_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00323","volume":"9","author":"S Ascough","year":"2018","unstructured":"Ascough S, Paterson S, Chiu C (2018) Induction and subversion of human protective immunity: contrasting influenza and respiratory syncytial virus. Front Immunol 9:323. https:\/\/doi.org\/10.3389\/fimmu.2018.00323","journal-title":"Front Immunol"},{"key":"6144_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40760-y","volume":"13","author":"TA Shishir","year":"2023","unstructured":"Shishir TA et al (2023) Genome-wide study of globally distributed respiratory syncytial virus (RSV) strains implicates diversification utilizing phylodynamics and mutational analysis. Sci Rep 13:13531. https:\/\/doi.org\/10.1038\/s41598-023-40760-y","journal-title":"Sci Rep"},{"key":"6144_CR3","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1128\/jvi.80.7.3675-3678.2006","volume":"80","author":"E Nobusawa","year":"2006","unstructured":"Nobusawa E, Sato K (2006) Comparison of the mutation rates of human influenza A and B viruses. J Virol 80:3675\u20133678. https:\/\/doi.org\/10.1128\/jvi.80.7.3675-3678.2006","journal-title":"J Virol"},{"key":"6144_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1558386","volume":"16","author":"S Xie","year":"2025","unstructured":"Xie S, Wei J, Wang X (2025) The intersection of influenza infection and autoimmunity. Front Immunol 16:1558386. https:\/\/doi.org\/10.3389\/fimmu.2025.1558386","journal-title":"Front Immunol"},{"key":"6144_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77369","volume":"17","author":"JT Johns","year":"2025","unstructured":"Johns JT (2025) Respiratory syncytial virus (RSV)-induced autoimmune hemolytic anemia presenting as syncope: a case report. Cureus 17:e77369. https:\/\/doi.org\/10.7759\/cureus.77369","journal-title":"Cureus"},{"key":"6144_CR6","doi-asserted-by":"publisher","DOI":"10.12890\/2024_004636","volume":"11","author":"M El Labban","year":"2024","unstructured":"El Labban M et al (2024) Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination. Eur J Case Rep Intern Med 11:004636. https:\/\/doi.org\/10.12890\/2024_004636","journal-title":"Eur J Case Rep Intern Med"},{"key":"6144_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jmv.27292","volume":"94","author":"N Yazdanpanah","year":"2022","unstructured":"Yazdanpanah N, Rezaei N (2022) Autoimmune complications of COVID-19. J Med Virol 94:54\u201362. https:\/\/doi.org\/10.1002\/jmv.27292","journal-title":"J Med Virol"},{"key":"6144_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109183","volume":"112","author":"M Vahabi","year":"2022","unstructured":"Vahabi M, Ghazanfari T, Sepehrnia S (2022) Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection. Int Immunopharmacol 112:109183. https:\/\/doi.org\/10.1016\/j.intimp.2022.109183","journal-title":"Int Immunopharmacol"},{"key":"6144_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/v11080762","author":"MK Smatti","year":"2019","unstructured":"Smatti MK et al (2019) Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. https:\/\/doi.org\/10.3390\/v11080762","journal-title":"Viruses"},{"key":"6144_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/v15030782","author":"B Sundaresan","year":"2023","unstructured":"Sundaresan B, Shirafkan F, Ripperger K, Rattay K (2023) The role of viral infections in the onset of autoimmune diseases. Viruses. https:\/\/doi.org\/10.3390\/v15030782","journal-title":"Viruses"},{"key":"6144_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1337406","volume":"15","author":"CO Hileman","year":"2024","unstructured":"Hileman CO, Malakooti SK, Patil N, Singer NG, McComsey GA (2024) New-onset autoimmune disease after COVID-19. Front Immunol 15:1337406. https:\/\/doi.org\/10.3389\/fimmu.2024.1337406","journal-title":"Front Immunol"},{"key":"6144_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1157023","volume":"2021","author":"AS Sameer","year":"2021","unstructured":"Sameer AS, Nissar S (2021) Toll-like receptors (TLRs): structure, functions, signaling, and role of their polymorphisms in colorectal cancer susceptibility. Biomed Res Int 2021:1157023. https:\/\/doi.org\/10.1155\/2021\/1157023","journal-title":"Biomed Res Int"},{"issue":"5","key":"6144_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01668-24","volume":"99","author":"R Ghimire","year":"2025","unstructured":"Ghimire R et al (2025) Toll-like receptor 7 (TLR7)-mediated antiviral response protects mice from lethal SARS-CoV-2 infection. J Virol 99(5):e01668-24. https:\/\/doi.org\/10.1128\/jvi.01668-24","journal-title":"J Virol"},{"issue":"1","key":"6144_CR14","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/s42003-024-06872-5","volume":"7","author":"C Wang","year":"2024","unstructured":"Wang C, Khatun MS, Ellsworth CR, Chen Z, Islamuddin M, Nisperuza Vidal AK, Afaque Alam M, Liu S, Maness NJ, Blair RV, Kolls JK, Qin X (2024) Deficiency of Tlr7 and Irf7 increases the severity of COVID-19 through the reduced interferon production. Commun Biol 7(1):1162. https:\/\/doi.org\/10.1038\/s42003-024-06872-5","journal-title":"Commun Biol"},{"key":"6144_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40114-8","volume":"13","author":"SM Naushad","year":"2023","unstructured":"Naushad SM, Mandadapu G, Ramaiah MJ, Almajhdi FN, Hussain T (2023) The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants. Sci Rep 13:13078. https:\/\/doi.org\/10.1038\/s41598-023-40114-8","journal-title":"Sci Rep"},{"key":"6144_CR16","doi-asserted-by":"publisher","first-page":"10988","DOI":"10.1128\/jvi.01064-12","volume":"86","author":"V Jeisy-Scott","year":"2012","unstructured":"Jeisy-Scott V et al (2012) TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice. J Virol 86:10988\u201310998. https:\/\/doi.org\/10.1128\/jvi.01064-12","journal-title":"J Virol"},{"key":"6144_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi9769","volume":"9","author":"C Wolf","year":"2024","unstructured":"Wolf C et al (2024) UNC93B1 variants underlie TLR7-dependent autoimmunity. Sci Immunol 9:eadi9769. https:\/\/doi.org\/10.1126\/sciimmunol.adi9769","journal-title":"Sci Immunol"},{"key":"6144_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","volume":"605","author":"GJ Brown","year":"2022","unstructured":"Brown GJ et al (2022) TLR7 gain-of-function genetic variation causes human lupus. Nature 605:349\u2013356. https:\/\/doi.org\/10.1038\/s41586-022-04642-z","journal-title":"Nature"},{"key":"6144_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/35100529","volume":"1","author":"R Medzhitov","year":"2001","unstructured":"Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135\u2013145. https:\/\/doi.org\/10.1038\/35100529","journal-title":"Nat Rev Immunol"},{"key":"6144_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2:675\u2013680. https:\/\/doi.org\/10.1038\/90609","journal-title":"Nat Immunol"},{"key":"6144_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1128\/cmr.16.4.637-646.2003","volume":"16","author":"S Janssens","year":"2003","unstructured":"Janssens S, Beyaert R (2003) Role of toll-like receptors in pathogen recognition. Clin Microbiol Rev 16:637\u2013646. https:\/\/doi.org\/10.1128\/cmr.16.4.637-646.2003","journal-title":"Clin Microbiol Rev"},{"key":"6144_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6978936","volume":"2016","author":"M Molteni","year":"2016","unstructured":"Molteni M, Gemma S, Rossetti C (2016) The role of toll-like receptor 4 in infectious and noninfectious inflammation. Mediators Inflamm 2016:6978936. https:\/\/doi.org\/10.1155\/2016\/6978936","journal-title":"Mediators Inflamm"},{"key":"6144_CR23","doi-asserted-by":"publisher","first-page":"12487","DOI":"10.1073\/pnas.0605200103","volume":"103","author":"V Feuillet","year":"2006","unstructured":"Feuillet V et al (2006) Involvement of toll-like receptor 5 in the recognition of flagellated bacteria. Proc Natl Acad Sci U S A 103:12487\u201312492. https:\/\/doi.org\/10.1073\/pnas.0605200103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6144_CR24","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","volume":"426","author":"SN Lester","year":"2014","unstructured":"Lester SN, Li K (2014) Toll-like receptors in antiviral innate immunity. J Mol Biol 426:1246\u20131264. https:\/\/doi.org\/10.1016\/j.jmb.2013.11.024","journal-title":"J Mol Biol"},{"key":"6144_CR25","doi-asserted-by":"publisher","unstructured":"Hornung V, Barchet W, Schlee M, Hartmann G (2008) RNA recognition via TLR7 and TLR8. Handb Exp Pharmacol, 71\u201386. https:\/\/doi.org\/10.1007\/978-3-540-72167-3_4","DOI":"10.1007\/978-3-540-72167-3_4"},{"key":"6144_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01075","volume":"8","author":"C Petes","year":"2017","unstructured":"Petes C, Odoardi N, Gee K (2017) The toll for trafficking: toll-like receptor 7 delivery to the endosome. Front Immunol 8:1075. https:\/\/doi.org\/10.3389\/fimmu.2017.01075","journal-title":"Front Immunol"},{"key":"6144_CR27","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41416-022-01876-6","volume":"127","author":"Z Dongye","year":"2022","unstructured":"Dongye Z, Li J, Wu Y (2022) Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity. Br J Cancer 127:1584\u20131594. https:\/\/doi.org\/10.1038\/s41416-022-01876-6","journal-title":"Br J Cancer"},{"key":"6144_CR28","doi-asserted-by":"publisher","DOI":"10.4110\/in.2020.20.e21","volume":"20","author":"F Fore","year":"2020","unstructured":"Fore F, Indriputri C, Mamutse J, Nugraha J (2020) TLR10 and its unique anti-inflammatory properties and potential use as a target in therapeutics. Immune Netw 20:e21. https:\/\/doi.org\/10.4110\/in.2020.20.e21","journal-title":"Immune Netw"},{"key":"6144_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/s1471-4906(02)02259-7","volume":"23","author":"M Rehli","year":"2002","unstructured":"Rehli M (2002) Of mice and men: species variations of Toll-like receptor expression. Trends Immunol 23:375\u2013378. https:\/\/doi.org\/10.1016\/s1471-4906(02)02259-7","journal-title":"Trends Immunol"},{"key":"6144_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05626-z","volume":"6","author":"C Wang","year":"2023","unstructured":"Wang C et al (2023) COVID-19 and influenza infections mediate distinct pulmonary cellular and transcriptomic changes. Commun Biol 6:1265. https:\/\/doi.org\/10.1038\/s42003-023-05626-z","journal-title":"Commun Biol"},{"key":"6144_CR31","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1172\/JCI44960","volume":"121","author":"M O\u2019Brien","year":"2011","unstructured":"O\u2019Brien M et al (2011) Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-\u03b1\u2013producing and partially matured phenotype. J Clin Invest 121:1088\u20131101. https:\/\/doi.org\/10.1172\/JCI44960","journal-title":"J Clin Invest"},{"key":"6144_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nri3133","volume":"12","author":"JM Gonzalez-Navajas","year":"2012","unstructured":"Gonzalez-Navajas JM, Lee J, David M, Raz E (2012) Immunomodulatory functions of type I interferons. Nat Rev Immunol 12:125\u2013135. https:\/\/doi.org\/10.1038\/nri3133","journal-title":"Nat Rev Immunol"},{"key":"6144_CR33","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1172\/JCI95375","volume":"127","author":"RT Veenhuis","year":"2017","unstructured":"Veenhuis RT et al (2017) HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells. J Clin Invest 127:4352\u20134364. https:\/\/doi.org\/10.1172\/JCI95375","journal-title":"J Clin Invest"},{"key":"6144_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005553","volume":"12","author":"M O\u2019Brien","year":"2016","unstructured":"O\u2019Brien M et al (2016) CD4 receptor is a key determinant of divergent HIV-1 sensing by plasmacytoid dendritic cells. PLoS Pathog 12:e1005553. https:\/\/doi.org\/10.1371\/journal.ppat.1005553","journal-title":"PLoS Pathog"},{"key":"6144_CR35","doi-asserted-by":"publisher","unstructured":"Hu J, Protzer U, Siddiqui A (2019) Revisiting hepatitis B virus: challenges of curative therapies - PubMed. J Virol 93. https:\/\/doi.org\/10.1128\/JVI.01032-19","DOI":"10.1128\/JVI.01032-19"},{"key":"6144_CR36","doi-asserted-by":"publisher","unstructured":"Gerlich WH, Robinson WS (1980) Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand - PubMed. Cell 21. https:\/\/doi.org\/10.1016\/0092-8674(80)90443-2","DOI":"10.1016\/0092-8674(80)90443-2"},{"key":"6144_CR37","doi-asserted-by":"publisher","unstructured":"Xu N, Yao HP, Lv GC, Chen Z (2012) Downregulation of TLR7\/9 leads to deficient production of IFN-\u03b1 from plasmacytoid dendritic cells in chronic hepatitis B - PubMed. Inflamm Res: Off J Eur Histamine Res Soc ... [et al.] 61. https:\/\/doi.org\/10.1007\/s00011-012-0493-z","DOI":"10.1007\/s00011-012-0493-z"},{"key":"6144_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2008.00711.x","author":"N Xu","year":"2008","unstructured":"Xu N et al (2008) Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis B and related hepatocellular carcinoma. Acta Pharmacol Sin. https:\/\/doi.org\/10.1111\/j.1745-7254.2008.00711.x","journal-title":"Acta Pharmacol Sin"},{"key":"6144_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.06.015","author":"K-J Lin","year":"2013","unstructured":"Lin K-J et al (2013) Down-regulation of Toll-like receptor 7 expression in hepatitis-virus\u2013related human hepatocellular carcinoma. Hum Pathol. https:\/\/doi.org\/10.1016\/j.humpath.2012.06.015","journal-title":"Hum Pathol"},{"key":"6144_CR40","doi-asserted-by":"publisher","DOI":"10.1159\/000430367","author":"T Tian","year":"2015","unstructured":"Tian T et al (2015) Roles of Toll-like receptor 7 and 8 in prevention of intrauterine transmission of hepatitis B virus. Cell Physiol Biochem. https:\/\/doi.org\/10.1159\/000430367","journal-title":"Cell Physiol Biochem"},{"key":"6144_CR41","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/nm.2004","volume":"15","author":"A Meier","year":"2009","unstructured":"Meier A et al (2009) Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15:955\u2013959. https:\/\/doi.org\/10.1038\/nm.2004","journal-title":"Nat Med"},{"key":"6144_CR42","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202201452","author":"F Abbas","year":"2022","unstructured":"Abbas F et al (2022) HIV-1 infection enhances innate function and TLR7 expression in female plasmacytoid dendritic cells. Life Sci Alliance. https:\/\/doi.org\/10.26508\/lsa.202201452","journal-title":"Life Sci Alliance"},{"key":"6144_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-1-r8","volume":"8","author":"MC Panelli","year":"2007","unstructured":"Panelli MC et al (2007) Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection. Genome Biol 8:R8. https:\/\/doi.org\/10.1186\/gb-2007-8-1-r8","journal-title":"Genome Biol"},{"key":"6144_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009244.pub3","author":"TB Pedersen","year":"2025","unstructured":"Pedersen TB, Pachler FR, Rosenberg J, Andresen K (2025) Interventions for anal canal intraepithelial neoplasia. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD009244.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"6144_CR45","doi-asserted-by":"publisher","unstructured":"Fayez NA et al (2022) Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen - PubMed. J Control Release: Off J Control Release Soc 350. https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.058","DOI":"10.1016\/j.jconrel.2022.08.058"},{"key":"6144_CR46","doi-asserted-by":"publisher","unstructured":"Hu Y et al (2020) A novel TLR7 agonist as adjuvant to stimulate high quality HBsAg-specific immune responses in an HBV mouse model. J Transl Med (1):18. https:\/\/doi.org\/10.1186\/s12967-020-02275-2","DOI":"10.1186\/s12967-020-02275-2"},{"key":"6144_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00727-7","author":"Y Mf","year":"2023","unstructured":"Mf Y et al (2023) TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(22)00727-7","journal-title":"Lancet Infect Dis"},{"key":"6144_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21893","volume":"9","author":"S Sahanic","year":"2023","unstructured":"Sahanic S et al (2023) SARS-CoV-2 activates the TLR4\/MyD88 pathway in human macrophages: a possible correlation with strong pro-inflammatory responses in severe COVID-19. Heliyon 9:e21893. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21893","journal-title":"Heliyon"},{"key":"6144_CR49","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2901008","volume":"29","author":"NJ Habeichi","year":"2024","unstructured":"Habeichi NJ et al (2024) Potential alternative receptors for SARS-CoV-2-induced kidney damage: TLR-4, KIM-1\/TIM-1, and CD147. Front Biosci Landmark 29:8. https:\/\/doi.org\/10.31083\/j.fbl2901008","journal-title":"Front Biosci Landmark"},{"key":"6144_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34297-3","volume":"13","author":"AS Ashhurst","year":"2022","unstructured":"Ashhurst AS et al (2022) Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice. Nat Commun 13:6972. https:\/\/doi.org\/10.1038\/s41467-022-34297-3","journal-title":"Nat Commun"},{"key":"6144_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94624-4","volume":"11","author":"MCS Menezes","year":"2021","unstructured":"Menezes MCS et al (2021) Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients. Sci Rep 11:15223. https:\/\/doi.org\/10.1038\/s41598-021-94624-4","journal-title":"Sci Rep"},{"key":"6144_CR52","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/jmv.27405","volume":"94","author":"M Manik","year":"2022","unstructured":"Manik M, Singh RK (2022) Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19. J Med Virol 94:869\u2013877. https:\/\/doi.org\/10.1002\/jmv.27405","journal-title":"J Med Virol"},{"key":"6144_CR53","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","volume":"180","author":"KA Fitzgerald","year":"2020","unstructured":"Fitzgerald KA, Kagan JC (2020) Toll-like receptors and the control of immunity. Cell 180:1044\u20131066. https:\/\/doi.org\/10.1016\/j.cell.2020.02.041","journal-title":"Cell"},{"key":"6144_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.xhgg.2024.100323","volume":"5","author":"J Boos","year":"2024","unstructured":"Boos J et al (2024) Stratified analyses refine association between TLR7 rare variants and severe COVID-19. Human Genetics and Genomics Advances 5:100323. https:\/\/doi.org\/10.1016\/j.xhgg.2024.100323","journal-title":"Human Genetics and Genomics Advances"},{"key":"6144_CR55","doi-asserted-by":"publisher","unstructured":"Fallerini C et al (2021) Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study. Elife 10. https:\/\/doi.org\/10.7554\/eLife.67569","DOI":"10.7554\/eLife.67569"},{"key":"6144_CR56","doi-asserted-by":"publisher","first-page":"114","DOI":"10.18502\/ijm.v16i1.14880","volume":"16","author":"M Parsania","year":"2024","unstructured":"Parsania M et al (2024) Association of polymorphisms in TLR3 and TLR7 genes with susceptibility to COVID-19 among Iranian population: a retrospective case-control study. Iran J Microbiol 16:114\u2013123. https:\/\/doi.org\/10.18502\/ijm.v16i1.14880","journal-title":"Iran J Microbiol"},{"key":"6144_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.114288","volume":"215","author":"A G\u00f3mez-Carballa","year":"2022","unstructured":"G\u00f3mez-Carballa A et al (2022) Sex-biased expression of the TLR7 gene in severe COVID-19 patients: insights from transcriptomics and epigenomics. Environ Res 215:114288. https:\/\/doi.org\/10.1016\/j.envres.2022.114288","journal-title":"Environ Res"},{"key":"6144_CR58","doi-asserted-by":"publisher","first-page":"27285","DOI":"10.1073\/pnas.2012520117","volume":"117","author":"V Galasso","year":"2020","unstructured":"Galasso V et al (2020) Gender differences in COVID-19 attitudes and behavior: panel evidence from eight countries. Proc Natl Acad Sci U S A 117:27285\u201327291. https:\/\/doi.org\/10.1073\/pnas.2012520117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6144_CR59","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1080\/15257770.2023.2176515","volume":"42","author":"G Bagci","year":"2023","unstructured":"Bagci G et al (2023) The investigation of host genetic variants of Toll-like receptor 7 and 8 in COVID-19. Nucleosides Nucleotides Nucleic Acids 42:586\u2013602. https:\/\/doi.org\/10.1080\/15257770.2023.2176515","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"6144_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010367","volume":"18","author":"G Butler-Laporte","year":"2022","unstructured":"Butler-Laporte G et al (2022) Exome-wide association study to identify rare variants influencing COVID-19 outcomes: results from the host genetics initiative. PLoS Genet 18:e1010367. https:\/\/doi.org\/10.1371\/journal.pgen.1010367","journal-title":"PLoS Genet"},{"key":"6144_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2020.109858","volume":"188","author":"A Angelopoulou","year":"2020","unstructured":"Angelopoulou A et al (2020) Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19. Environ Res 188:109858. https:\/\/doi.org\/10.1016\/j.envres.2020.109858","journal-title":"Environ Res"},{"key":"6144_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.989664","volume":"13","author":"ZM Liu","year":"2022","unstructured":"Liu ZM, Yang MH, Yu K, Lian ZX, Deng SL (2022) Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments. Front Pharmacol 13:989664. https:\/\/doi.org\/10.3389\/fphar.2022.989664","journal-title":"Front Pharmacol"},{"key":"6144_CR63","doi-asserted-by":"publisher","unstructured":"Salvi V et al (2021) SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7\/8. JCI Insight 6. https:\/\/doi.org\/10.1172\/jci.insight.150542","DOI":"10.1172\/jci.insight.150542"},{"key":"6144_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34895-1","volume":"13","author":"N Smith","year":"2022","unstructured":"Smith N et al (2022) Defective activation and regulation of type I interferon immunity\u00a0is associated with increasing COVID-19 severity. Nat Commun 13:7254. https:\/\/doi.org\/10.1038\/s41467-022-34895-1","journal-title":"Nat Commun"},{"key":"6144_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719115","volume":"12","author":"X Solanich","year":"2021","unstructured":"Solanich X et al (2021) Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19. Front Immunol 12:719115. https:\/\/doi.org\/10.3389\/fimmu.2021.719115","journal-title":"Front Immunol"},{"key":"6144_CR66","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/jama.2020.13719","volume":"324","author":"CI van der Made","year":"2020","unstructured":"van der Made CI et al (2020) Presence of genetic variants among young men with severe COVID-19. JAMA 324:663\u2013673. https:\/\/doi.org\/10.1001\/jama.2020.13719","journal-title":"JAMA"},{"key":"6144_CR67","doi-asserted-by":"publisher","unstructured":"Asano T et al. (2021) X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol 6. https:\/\/doi.org\/10.1126\/sciimmunol.abl4348","DOI":"10.1126\/sciimmunol.abl4348"},{"key":"6144_CR68","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41435-021-00157-1","volume":"23","author":"S Mantovani","year":"2022","unstructured":"Mantovani S et al (2022) Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients. Genes Immun 23:51\u201356. https:\/\/doi.org\/10.1038\/s41435-021-00157-1","journal-title":"Genes Immun"},{"key":"6144_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","author":"Q Zhang","year":"2020","unstructured":"Zhang Q et al (2020) Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. https:\/\/doi.org\/10.1126\/science.abd4570","journal-title":"Science"},{"key":"6144_CR70","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Garc\u00eda A et al (2023) Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia. J Exp Med 220. https:\/\/doi.org\/10.1084\/jem.20220170","DOI":"10.1084\/jem.20220170"},{"key":"6144_CR71","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01668-24","volume":"99","author":"R Ghimire","year":"2025","unstructured":"Ghimire R et al (2025) Toll-like receptor 7 (TLR7)-mediated antiviral response protects mice from lethal SARS-CoV-2 infection. J Virol 99:e01668-01624. https:\/\/doi.org\/10.1128\/jvi.01668-24","journal-title":"J Virol"},{"key":"6144_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06872-5","volume":"7","author":"C Wang","year":"2024","unstructured":"Wang C et al (2024) Deficiency of Tlr7 and Irf7 in mice increases the severity of COVID-19 through the reduced interferon production. Commun Biol 7:1162. https:\/\/doi.org\/10.1038\/s42003-024-06872-5","journal-title":"Commun Biol"},{"key":"6144_CR73","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1089\/vim.2024.0025","volume":"37","author":"N Ghorra","year":"2024","unstructured":"Ghorra N et al (2024) Cytokine profile in patients with postacute sequelae of COVID-19. Viral Immunol 37:346\u2013354. https:\/\/doi.org\/10.1089\/vim.2024.0025","journal-title":"Viral Immunol"},{"key":"6144_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1268035","volume":"14","author":"A Noor Eddin","year":"2023","unstructured":"Noor Eddin A, Al-Rimawi M, Peer-Zada F, Hundallah K, Alhashem A (2023) Novel TLR7 hemizygous variant in post-COVID-19 neurological deterioration: a case report with literature review. Front Neurol 14:1268035. https:\/\/doi.org\/10.3389\/fneur.2023.1268035","journal-title":"Front Neurol"},{"key":"6144_CR75","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1021\/acsmedchemlett.4c00200","volume":"15","author":"K Kumar","year":"2024","unstructured":"Kumar K et al (2024) Modulation of the adjuvant potential of Imidazoquinoline-based TLR7\/8 agonists via alum adsorption. ACS Med Chem Lett 15:1677\u20131684. https:\/\/doi.org\/10.1021\/acsmedchemlett.4c00200","journal-title":"ACS Med Chem Lett"},{"key":"6144_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/v11040346","author":"I Kosik","year":"2019","unstructured":"Kosik I, Yewdell JW (2019) Influenza hemagglutinin and neuraminidase: yin\u2013yang proteins coevolving to thwart immunity. Viruses. https:\/\/doi.org\/10.3390\/v11040346","journal-title":"Viruses"},{"key":"6144_CR77","doi-asserted-by":"publisher","unstructured":"Kim H, Webster RG, Webby RJ (2018) Influenza virus: dealing with a drifting and shifting pathogen - PubMed. Viral Immunol 31. https:\/\/doi.org\/10.1089\/vim.2017.0141","DOI":"10.1089\/vim.2017.0141"},{"key":"6144_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7305a1","volume":"73","author":"LA Grohskopf","year":"2024","unstructured":"Grohskopf LA, Ferdinands JM, Blanton LH, Broder KR, Loehr J (2024) Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2024-25 influenza season. MMWR Recomm Rep 73:1\u201325. https:\/\/doi.org\/10.15585\/mmwr.rr7305a1","journal-title":"MMWR Recomm Rep"},{"key":"6144_CR79","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genet-120116-023425","author":"AD Kenney","year":"2017","unstructured":"Kenney AD et al (2017) Human genetic determinants of viral diseases. Annu Rev Genet. https:\/\/doi.org\/10.1146\/annurev-genet-120116-023425","journal-title":"Annu Rev Genet"},{"key":"6144_CR80","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s11033-011-0846-7","volume":"39","author":"Y Liu","year":"2012","unstructured":"Liu Y, Chen H, Sun Y, Chen F (2012) Antiviral role of Toll-like receptors and cytokines against the new 2009 H1N1 virus infection. Mol Biol Rep 39:1163\u20131172. https:\/\/doi.org\/10.1007\/s11033-011-0846-7","journal-title":"Mol Biol Rep"},{"key":"6144_CR81","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/eji.200425583","volume":"35","author":"W Barchet","year":"2005","unstructured":"Barchet W et al (2005) Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways. Eur J Immunol 35:236\u2013242. https:\/\/doi.org\/10.1002\/eji.200425583","journal-title":"Eur J Immunol"},{"key":"6144_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413699","author":"MA Miles","year":"2024","unstructured":"Miles MA et al (2024) TLR7 promotes acute inflammatory-driven lung dysfunction in influenza-infected mice but prevents late airway hyperresponsiveness. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252413699","journal-title":"Int J Mol Sci"},{"key":"6144_CR83","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3109\/10715762.2014.927579","volume":"48","author":"EE To","year":"2014","unstructured":"To EE, Broughton BR, Hendricks KS, Vlahos R, Selemidis S (2014) Influenza A virus and TLR7 activation potentiate NOX2 oxidase-dependent ROS production in macrophages. Free Radic Res 48:940\u2013947. https:\/\/doi.org\/10.3109\/10715762.2014.927579","journal-title":"Free Radic Res"},{"key":"6144_CR84","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s40121-024-01034-w","volume":"13","author":"SA Riddler","year":"2024","unstructured":"Riddler SA et al (2024) A pooled analysis of eight clinical studies suggests a link between influenza-like symptoms and pharmacodynamics of the Toll-Like Receptor-7 agonist Vesatolimod. Infect Dis Ther 13:2285\u20132299. https:\/\/doi.org\/10.1007\/s40121-024-01034-w","journal-title":"Infect Dis Ther"},{"key":"6144_CR85","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1182\/blood-2008-01-132860","volume":"112","author":"JP Wang","year":"2008","unstructured":"Wang JP et al (2008) Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 112:2028\u20132034. https:\/\/doi.org\/10.1182\/blood-2008-01-132860","journal-title":"Blood"},{"key":"6144_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00245","volume":"9","author":"S Stegemann-Koniszewski","year":"2018","unstructured":"Stegemann-Koniszewski S et al (2018) Respiratory influenza A virus infection triggers local and systemic natural killer cell activation via Toll-like receptor 7. Front Immunol 9:245. https:\/\/doi.org\/10.3389\/fimmu.2018.00245","journal-title":"Front Immunol"},{"key":"6144_CR87","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.4049\/jimmunol.179.7.4711","volume":"179","author":"S Koyama","year":"2007","unstructured":"Koyama S et al (2007) Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol 179:4711\u20134720. https:\/\/doi.org\/10.4049\/jimmunol.179.7.4711","journal-title":"J Immunol"},{"key":"6144_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063163","volume":"8","author":"N Budimir","year":"2013","unstructured":"Budimir N et al (2013) Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine. PLoS One 8:e63163. https:\/\/doi.org\/10.1371\/journal.pone.0063163","journal-title":"PLoS One"},{"key":"6144_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.01.011","author":"B Hou","year":"2011","unstructured":"Hou B et al (2011) Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the anti-viral germinal center response. Immunity. https:\/\/doi.org\/10.1016\/j.immuni.2011.01.011","journal-title":"Immunity"},{"key":"6144_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38864-5","volume":"9","author":"EE To","year":"2019","unstructured":"To EE et al (2019) Intranasal and epicutaneous administration of Toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice. Sci Rep 9:2366. https:\/\/doi.org\/10.1038\/s41598-019-38864-5","journal-title":"Sci Rep"},{"key":"6144_CR91","doi-asserted-by":"publisher","unstructured":"Curtsinger JM, Valenzuela JO, Agarwal P, Lins D, Mescher MF (2005) Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation - PubMed. J Immunol (Baltimore, Md. : 1950) 174. https:\/\/doi.org\/10.4049\/jimmunol.174.8.4465","DOI":"10.4049\/jimmunol.174.8.4465"},{"key":"6144_CR92","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2079322","volume":"18","author":"E Baraldi","year":"2022","unstructured":"Baraldi E et al (2022) RSV disease in infants and young children: can we see a brighter future? Hum Vaccin Immunother 18:2079322. https:\/\/doi.org\/10.1080\/21645515.2022.2079322","journal-title":"Hum Vaccin Immunother"},{"key":"6144_CR93","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-642-38919-1_1","volume":"372","author":"PL Collins","year":"2013","unstructured":"Collins PL, Fearns R, Graham BS (2013) Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Curr Top Microbiol Immunol 372:3\u201338. https:\/\/doi.org\/10.1007\/978-3-642-38919-1_1","journal-title":"Curr Top Microbiol Immunol"},{"key":"6144_CR94","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41579-019-0149-x","volume":"17","author":"MB Battles","year":"2019","unstructured":"Battles MB, McLellan JS (2019) Respiratory syncytial virus entry and how to block it. Nat Rev Microbiol 17:233\u2013245. https:\/\/doi.org\/10.1038\/s41579-019-0149-x","journal-title":"Nat Rev Microbiol"},{"key":"6144_CR95","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.7150\/ijbs.64762","volume":"17","author":"Z Shang","year":"2021","unstructured":"Shang Z, Tan S, Ma D (2021) Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies. Int J Biol Sci 17:4073\u20134091. https:\/\/doi.org\/10.7150\/ijbs.64762","journal-title":"Int J Biol Sci"},{"key":"6144_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.865592","volume":"13","author":"Y Ouyang","year":"2022","unstructured":"Ouyang Y et al (2022) Innate immune evasion by human respiratory syncytial virus. Front Microbiol 13:865592. https:\/\/doi.org\/10.3389\/fmicb.2022.865592","journal-title":"Front Microbiol"},{"key":"6144_CR97","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1128\/cmr.00017-08","volume":"21","author":"I Miyairi","year":"2008","unstructured":"Miyairi I, DeVincenzo JP (2008) Human genetic factors and respiratory syncytial virus disease severity. Clin Microbiol Rev 21:686\u2013703. https:\/\/doi.org\/10.1128\/cmr.00017-08","journal-title":"Clin Microbiol Rev"},{"key":"6144_CR98","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1086\/420830","volume":"189","author":"G Tal","year":"2004","unstructured":"Tal G et al (2004) Association between common Toll-Like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 189:2057\u20132063. https:\/\/doi.org\/10.1086\/420830","journal-title":"J Infect Dis"},{"key":"6144_CR99","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1152\/physiolgenomics.00101.2019","volume":"51","author":"J Marzec","year":"2019","unstructured":"Marzec J et al (2019) Toll-like receptor 4-mediated respiratory syncytial virus disease and lung transcriptomics in differentially susceptible inbred mouse strains. Physiol Genomics 51:630\u2013643. https:\/\/doi.org\/10.1152\/physiolgenomics.00101.2019","journal-title":"Physiol Genomics"},{"key":"6144_CR100","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/80833","volume":"1","author":"EA Kurt-Jones","year":"2000","unstructured":"Kurt-Jones EA et al (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398\u2013401. https:\/\/doi.org\/10.1038\/80833","journal-title":"Nat Immunol"},{"key":"6144_CR101","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1086\/597386","volume":"199","author":"JL Reed","year":"2009","unstructured":"Reed JL et al (2009) Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection. J Infect Dis 199:1128\u20131138. https:\/\/doi.org\/10.1086\/597386","journal-title":"J Infect Dis"},{"key":"6144_CR102","doi-asserted-by":"publisher","unstructured":"Correa D, Giraldo DM, Gallego S, Taborda NA, Hernandez JC (2023) Immunity towards human respiratory syncytial virus. Acta Virol 67. https:\/\/doi.org\/10.3389\/av.2023.11887","DOI":"10.3389\/av.2023.11887"},{"key":"6144_CR103","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00705-018-3739-4","volume":"163","author":"T Sun","year":"2018","unstructured":"Sun T, Yu HY, Zhang CL, Zhu TN, Huang SH (2018) Respiratory syncytial virus infection up-regulates TLR7 expression by inducing oxidative stress via the Nrf2\/ARE pathway in A549 cells. Arch Virol 163:1209\u20131217. https:\/\/doi.org\/10.1007\/s00705-018-3739-4","journal-title":"Arch Virol"},{"key":"6144_CR104","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.intimp.2015.10.022","volume":"29","author":"F Qi","year":"2015","unstructured":"Qi F et al (2015) Respiratory macrophages and dendritic cells mediate respiratory syncytial virus-induced IL-33 production in TLR3- or TLR7-dependent manner. Int Immunopharmacol 29:408\u2013415. https:\/\/doi.org\/10.1016\/j.intimp.2015.10.022","journal-title":"Int Immunopharmacol"},{"key":"6144_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1240552","volume":"14","author":"MA Miles","year":"2023","unstructured":"Miles MA et al (2023) TLR7 promotes chronic airway disease in RSV-infected mice. Front Immunol 14:1240552. https:\/\/doi.org\/10.3389\/fimmu.2023.1240552","journal-title":"Front Immunol"},{"key":"6144_CR106","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1016\/j.vaccine.2009.03.026","volume":"27","author":"TR Johnson","year":"2009","unstructured":"Johnson TR, Rao S, Seder RA, Chen M, Graham BS (2009) TLR9 agonist, but not TLR7\/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity. Vaccine 27:3045\u20133052. https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.026","journal-title":"Vaccine"},{"key":"6144_CR107","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.4049\/jimmunol.1000733","volume":"185","author":"NW Lukacs","year":"2010","unstructured":"Lukacs NW et al (2010) Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J Immunol 185:2231\u20132239. https:\/\/doi.org\/10.4049\/jimmunol.1000733","journal-title":"J Immunol"},{"key":"6144_CR108","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85647","author":"WD Jackson","year":"2023","unstructured":"Jackson WD et al (2023) TLR7 activation at epithelial barriers promotes emergency myelopoiesis and lung antiviral immunity. Elife. https:\/\/doi.org\/10.7554\/eLife.85647","journal-title":"Elife"},{"key":"6144_CR109","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.4049\/jimmunol.1002635","volume":"186","author":"S Davidson","year":"2011","unstructured":"Davidson S et al (2011) Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway. J Immunol 186:5938\u20135948. https:\/\/doi.org\/10.4049\/jimmunol.1002635","journal-title":"J Immunol"},{"key":"6144_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104817","volume":"179","author":"FM Salinas","year":"2020","unstructured":"Salinas FM et al (2020) Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs. Antiviral Res 179:104817. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104817","journal-title":"Antiviral Res"},{"key":"6144_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/v11080730","author":"TH Kim","year":"2019","unstructured":"Kim TH, Oh DS, Jung HE, Chang J, Lee HK (2019) Plasmacytoid dendritic cells contribute to the production of IFN-\u03b2 via TLR7-MyD88-dependent pathway and CTL priming during respiratory syncytial virus infection. Viruses. https:\/\/doi.org\/10.3390\/v11080730","journal-title":"Viruses"},{"key":"6144_CR112","doi-asserted-by":"publisher","DOI":"10.4110\/in.2021.21.e27","volume":"21","author":"TH Kim","year":"2021","unstructured":"Kim TH, Kim CW, Oh DS, Jung HE, Lee HK (2021) Monocytes contribute to IFN-\u03b2 production via the MyD88-dependent pathway and cytotoxic T-cell responses against mucosal respiratory syncytial virus infection. Immune Netw 21:e27. https:\/\/doi.org\/10.4110\/in.2021.21.e27","journal-title":"Immune Netw"},{"key":"6144_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088764","volume":"9","author":"TM Wong","year":"2014","unstructured":"Wong TM et al (2014) Respiratory syncytial virus (RSV) infection in elderly mice results in altered antiviral gene expression and enhanced pathology. PLoS One 9:e88764. https:\/\/doi.org\/10.1371\/journal.pone.0088764","journal-title":"PLoS One"},{"key":"6144_CR114","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1128\/jvi.00671-08","volume":"83","author":"MR Murawski","year":"2009","unstructured":"Murawski MR et al (2009) Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol 83:1492\u20131500. https:\/\/doi.org\/10.1128\/jvi.00671-08","journal-title":"J Virol"},{"key":"6144_CR115","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","volume":"19","author":"DS Pisetsky","year":"2023","unstructured":"Pisetsky DS (2023) Pathogenesis of autoimmune disease. Nat Rev Nephrol 19:509\u2013524. https:\/\/doi.org\/10.1038\/s41581-023-00720-1","journal-title":"Nat Rev Nephrol"},{"key":"6144_CR116","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/joim.12395","volume":"278","author":"L Wang","year":"2015","unstructured":"Wang L, Wang FS, Gershwin ME (2015) Human autoimmune diseases: a comprehensive update. J Intern Med 278:369\u2013395. https:\/\/doi.org\/10.1111\/joim.12395","journal-title":"J Intern Med"},{"key":"6144_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116133","author":"C Wang","year":"2024","unstructured":"Wang C et al (2024) The role of TLR7 and TLR9 in the pathogenesis of systemic sclerosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25116133","journal-title":"Int J Mol Sci"},{"key":"6144_CR118","doi-asserted-by":"publisher","first-page":"Itc81","DOI":"10.7326\/aitc202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL (2020) Systemic lupus erythematosus. Ann Intern Med 172:Itc81-itc96. https:\/\/doi.org\/10.7326\/aitc202006020","journal-title":"Ann Intern Med"},{"key":"6144_CR119","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","volume":"56","author":"F Rees","year":"2017","unstructured":"Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W (2017) The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford) 56:1945\u20131961. https:\/\/doi.org\/10.1093\/rheumatology\/kex260","journal-title":"Rheumatology (Oxford)"},{"key":"6144_CR120","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/bor.0000000000000480","volume":"30","author":"G Stojan","year":"2018","unstructured":"Stojan G, Petri M (2018) Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol 30:144\u2013150. https:\/\/doi.org\/10.1097\/bor.0000000000000480","journal-title":"Curr Opin Rheumatol"},{"key":"6144_CR121","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/0961203315627202","volume":"25","author":"YH Lee","year":"2016","unstructured":"Lee YH, Choi SJ, Ji JD, Song GG (2016) Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus 25:727\u2013734. https:\/\/doi.org\/10.1177\/0961203315627202","journal-title":"Lupus"},{"key":"6144_CR122","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2024.2325438","author":"YE Nakazawa-Ueji","year":"2024","unstructured":"Nakazawa-Ueji YE et al (2024) Association of the polymorphisms rs179008 (TLR7), rs2004640 (IRF5), rs1800795 (IL-6) and rs2280788 (CCL5) with systemic lupus erythematosus in women of Mayan ethnicity from Yucatan. Nucleosides Nucleotides Nucleic Acids. https:\/\/doi.org\/10.1080\/15257770.2024.2325438","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"6144_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11680","volume":"8","author":"MM Azab","year":"2022","unstructured":"Azab MM et al (2022) Association of TLR7 and TLR9 genes polymorphisms in Egyptian patients with systemic lupus erythematosus. Heliyon 8:e11680. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11680","journal-title":"Heliyon"},{"key":"6144_CR124","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2553901","volume":"2022","author":"GV Pacheco","year":"2022","unstructured":"Pacheco GV et al (2022) Copy number variation and frequency of rs179008 in TLR7 gene associated with systemic lupus erythematosus in two Mexican populations. J Immunol Res 2022:2553901. https:\/\/doi.org\/10.1155\/2022\/2553901","journal-title":"J Immunol Res"},{"key":"6144_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1441-7","volume":"19","author":"G Murayama","year":"2017","unstructured":"Murayama G et al (2017) Enhanced IFN-\u03b1 production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res Ther 19:234. https:\/\/doi.org\/10.1186\/s13075-017-1441-7","journal-title":"Arthritis Res Ther"},{"key":"6144_CR126","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00281-018-0712-y","volume":"41","author":"M Souyris","year":"2019","unstructured":"Souyris M, Mej\u00eda JE, Chaumeil J, Gu\u00e9ry JC (2019) Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation. Semin Immunopathol 41:153\u2013164. https:\/\/doi.org\/10.1007\/s00281-018-0712-y","journal-title":"Semin Immunopathol"},{"key":"6144_CR127","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.cell.2021.02.015","volume":"184","author":"B Yu","year":"2021","unstructured":"Yu B et al (2021) B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells. Cell 184:1790-1803.e1717. https:\/\/doi.org\/10.1016\/j.cell.2021.02.015","journal-title":"Cell"},{"key":"6144_CR128","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2016-000199","volume":"5","author":"ML Richard","year":"2018","unstructured":"Richard ML, Gilkeson G (2018) Mouse models of lupus: what they tell us and what they don\u2019t. Lupus Sci Med 5:e000199. https:\/\/doi.org\/10.1136\/lupus-2016-000199","journal-title":"Lupus Sci Med"},{"key":"6144_CR129","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1073\/pnas.1916897117","volume":"117","author":"RR Goel","year":"2020","unstructured":"Goel RR et al (2020) Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus. Proc Natl Acad Sci U S A 117:5409\u20135419. https:\/\/doi.org\/10.1073\/pnas.1916897117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6144_CR130","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172219","author":"HA Cosgrove","year":"2023","unstructured":"Cosgrove HA et al (2023) B cell-intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.172219","journal-title":"JCI Insight"},{"key":"6144_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111794","volume":"141","author":"SR Dyavar","year":"2021","unstructured":"Dyavar SR et al (2021) Role of Toll-like receptor 7\/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options. Biomed Pharmacother 141:111794. https:\/\/doi.org\/10.1016\/j.biopha.2021.111794","journal-title":"Biomed Pharmacother"},{"key":"6144_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32752","volume":"10","author":"Y Zhang","year":"2024","unstructured":"Zhang Y et al (2024) Investigating the therapeutic mechanism of Jiedu-Quyu-Ziyin Fang on systemic lupus erythematosus through the ER\u03b1-miRNA-TLR7 immune axis. Heliyon 10:e32752. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32752","journal-title":"Heliyon"},{"key":"6144_CR133","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/ni.3731","volume":"18","author":"AN Theofilopoulos","year":"2017","unstructured":"Theofilopoulos AN, Kono DH, Baccala R (2017) The multiple pathways to autoimmunity. Nat Immunol 18:716\u2013724. https:\/\/doi.org\/10.1038\/ni.3731","journal-title":"Nat Immunol"},{"key":"6144_CR134","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.immuni.2016.09.011","volume":"45","author":"Z Zhang","year":"2016","unstructured":"Zhang Z et al (2016) Structural analysis reveals that Toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA. Immunity 45:737\u2013748. https:\/\/doi.org\/10.1016\/j.immuni.2016.09.011","journal-title":"Immunity"},{"key":"6144_CR135","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41584-020-00544-4","volume":"17","author":"S Fillatreau","year":"2021","unstructured":"Fillatreau S, Manfroi B, D\u00f6rner T (2021) Toll-like receptor signalling in B cells during systemic lupus erythematosus. Nat Rev Rheumatol 17:98\u2013108. https:\/\/doi.org\/10.1038\/s41584-020-00544-4","journal-title":"Nat Rev Rheumatol"},{"key":"6144_CR136","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01047-1","volume":"23","author":"AB Satterthwaite","year":"2021","unstructured":"Satterthwaite AB (2021) TLR7 signaling in lupus B cells: new insights into synergizing factors and downstream signals. Curr Rheumatol Rep 23:80. https:\/\/doi.org\/10.1007\/s11926-021-01047-1","journal-title":"Curr Rheumatol Rep"},{"key":"6144_CR137","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","volume":"6","author":"LE Mu\u00f1oz","year":"2010","unstructured":"Mu\u00f1oz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M (2010) The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 6:280\u2013289. https:\/\/doi.org\/10.1038\/nrrheum.2010.46","journal-title":"Nat Rev Rheumatol"},{"key":"6144_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/antib12010004","author":"T Amendt","year":"2023","unstructured":"Amendt T, Yu P (2023) TLR7 and IgM: dangerous partners in autoimmunity. Antibodies (Basel). https:\/\/doi.org\/10.3390\/antib12010004","journal-title":"Antibodies (Basel)"},{"key":"6144_CR139","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler EC et al (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100:2610\u20132615. https:\/\/doi.org\/10.1073\/pnas.0337679100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6144_CR140","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1084\/jem.20021553","volume":"197","author":"L Bennett","year":"2003","unstructured":"Bennett L et al (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197:711\u2013723. https:\/\/doi.org\/10.1084\/jem.20021553","journal-title":"J Exp Med"},{"key":"6144_CR141","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1002\/art.21890","volume":"54","author":"J Hua","year":"2006","unstructured":"Hua J, Kirou K, Lee C, Crow MK (2006) Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 54:1906\u20131916. https:\/\/doi.org\/10.1002\/art.21890","journal-title":"Arthritis Rheum"},{"key":"6144_CR142","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-3-540-71329-6_17","volume":"316","author":"MK Crow","year":"2007","unstructured":"Crow MK (2007) Type I interferon in systemic lupus erythematosus. Curr Top Microbiol Immunol 316:359\u2013386. https:\/\/doi.org\/10.1007\/978-3-540-71329-6_17","journal-title":"Curr Top Microbiol Immunol"},{"key":"6144_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25102-8","volume":"12","author":"E Ricker","year":"2021","unstructured":"Ricker E et al (2021) Altered function and differentiation of age-associated B cells contribute to the female bias in lupus mice. Nat Commun 12:4813. https:\/\/doi.org\/10.1038\/s41467-021-25102-8","journal-title":"Nat Commun"},{"key":"6144_CR144","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks SA et al (2018) Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49:725-739.e726. https:\/\/doi.org\/10.1016\/j.immuni.2018.08.015","journal-title":"Immunity"},{"key":"6144_CR145","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1126\/science.1064890","volume":"294","author":"P Blanco","year":"2001","unstructured":"Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294:1540\u20131543. https:\/\/doi.org\/10.1126\/science.1064890","journal-title":"Science"},{"key":"6144_CR146","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","volume":"15","author":"M Swiecki","year":"2015","unstructured":"Swiecki M, Colonna M (2015) The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol 15:471\u2013485. https:\/\/doi.org\/10.1038\/nri3865","journal-title":"Nat Rev Immunol"},{"key":"6144_CR147","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.intimp.2019.03.010","volume":"72","author":"A Mohamed","year":"2019","unstructured":"Mohamed A et al (2019) Therapeutic advances in the treatment of SLE. Int Immunopharmacol 72:218\u2013223. https:\/\/doi.org\/10.1016\/j.intimp.2019.03.010","journal-title":"Int Immunopharmacol"},{"key":"6144_CR148","doi-asserted-by":"publisher","first-page":"v19","DOI":"10.1093\/rheumatology\/keaa420","volume":"59","author":"V Golder","year":"2020","unstructured":"Golder V, Tsang ASMWP (2020) Treatment targets in SLE: remission and low disease activity state. Rheumatology (Oxford) 59:v19\u2013v28. https:\/\/doi.org\/10.1093\/rheumatology\/keaa420","journal-title":"Rheumatology (Oxford)"},{"key":"6144_CR149","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1124\/jpet.120.000275","volume":"376","author":"J Vlach","year":"2021","unstructured":"Vlach J et al (2021) Discovery of M5049: a novel selective Toll-like receptor 7\/8 inhibitor for treatment of autoimmunity. J Pharmacol Exp Ther 376:397\u2013409. https:\/\/doi.org\/10.1124\/jpet.120.000275","journal-title":"J Pharmacol Exp Ther"},{"key":"6144_CR150","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.842","volume":"9","author":"A Port","year":"2021","unstructured":"Port A et al (2021) Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of Toll-like receptors 7 and 8. Pharmacol Res Perspect 9:e00842. https:\/\/doi.org\/10.1002\/prp2.842","journal-title":"Pharmacol Res Perspect"},{"key":"6144_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101036","volume":"4","author":"S Hawtin","year":"2023","unstructured":"Hawtin S et al (2023) Preclinical characterization of the Toll-like receptor 7\/8 antagonist MHV370 for lupus therapy. Cell Rep Med 4:101036. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101036","journal-title":"Cell Rep Med"},{"key":"6144_CR152","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s13318-023-00847-3","volume":"48","author":"T Shisha","year":"2023","unstructured":"Shisha T et al (2023) First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of MHV370, a dual inhibitor of Toll-Like Receptors 7 and 8, in healthy adults. Eur J Drug Metab Pharmacokinet 48:553\u2013566. https:\/\/doi.org\/10.1007\/s13318-023-00847-3","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"6144_CR153","doi-asserted-by":"publisher","first-page":"175962","DOI":"10.1016\/j.ejphar.2023.175962","volume":"957","author":"ST Ishizaka","year":"2023","unstructured":"Ishizaka ST et al (2023) A novel Toll-like receptor 7\/8-specific antagonist E6742 ameliorates clinically relevant disease parameters in murine models of lupus. Eur J Pharmacol 957:175962. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175962","journal-title":"Eur J Pharmacol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06144-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06144-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06144-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:36:11Z","timestamp":1773894971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06144-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6144"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06144-x","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest. Authors have no relevant financial and non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"152"}}